You are here

Study Evaluating Safety And Tolerability Of Meningococcal B Rlp2086 Vaccine In Healthy Adults

Last updated on March 15, 2019

FOR MORE INFORMATION
Study Location
Miami Research Associates, Inc.
South Miami, Florida, 33143 United States
Contact
1-800-718-1021
Eligibility criteria
Condition
The disease, disorder, syndrome, illness, or injury that is being studied.
Meningococcal Meningitis
Sex
Females and Males
Age
Pediatric Trials: 0-17 Years
Adult Trials: 18+ Years
18-40 years
Inclusion criteria
The factors, or reasons, that allow a person to participate in a clinical study.
Show details

A subject must meet the following inclusion criteria at screening (visit 1) and at
randomization (visit 2) to be considered for enrollment in the study:

- Male or female subjects between the ages of 18 and 40.

- Healthy male or female subjects as determined by medical history, physical
examination, and judgment of the investigator.

- Male or female subject who is considered biologically capable of having children must
agree to commit to the use of a reliable method of birth control for the duration of
the study and for 30 days after early discontinuation. A subject is still biologically
capable of having children, even if he or she is using contraceptives or if his or her
sexual partner is sterile or using contraceptives.

In addition a subject must meet the following inclusion criteria at randomization (visit 2)
to be considered for enrollment in the study. The referred blood and urinalysis tests
(inclusion criterion 5) will be performed on a blood and urine sample taken at visit 1:

- Female subjects of childbearing potential with a negative urine pregnancy test prior
to study drug administration. Note: this criterion will apply to each vaccination
visit and to the last study visit.

- Laboratory blood and urinalysis tests results within the per-protocol normal ranges.

- Able to be contacted by telephone during the study period. Note: this criterion will
apply to each study visit.

Exclusion criteria
The factors, or reasons, that prevent a person from participating in a clinical study.
Show details
NCT00879814
Pfizer
Completed
Study Evaluating Safety And Tolerability Of Meningococcal B Rlp2086 Vaccine In Healthy Adults

NEED INFO?

Questions about a trial? Call or email to reach a Pfizer Clinical Trial Contact Center

Pfizer Clinical Trials Contact Center

1-800-718-1021

[email protected]

call now

Try a new search

Search for Clinical Trials by condition, keyword or trial number. Share your location or enter your city or zip code to find studies near you.

Based on your search, you may also be interested in

Meningococcal Meningitis
NCT00297687
All Genders
18+
Years
Multiple Sites
Meningococcal Meningitis
NCT00879814
All Genders
18+
Years
South Miami, Florida
Meningococcal Meningitis
NCT00780806
All Genders
18+
Years
Multiple Sites

FOR MORE INFORMATION

Contact a representative by phone, email, or visiting the study website. Please see the references below:

BY PHONE

Pfizer Clinical Trials Contact Center

1-800-718-1021

BY EMAIL

Contact

[email protected]

Call Now